Reported Cases and Deaths of National Notifiable Infectious Diseases-China,August 2022
-
1Reported Cases and Deaths of National Notifiable Infectious Diseases-China,February 2022[J].China CDC weekly,2022,4(17):374-375.
-
2Reported Cases and Deaths of National Notifiable Infectious Diseases—China,May 2022[J].China CDC weekly,2022,4(29):646-647.
-
3Reported Cases and Deaths of National Notifiable Infectious Diseases-China,June 2022[J].China CDC weekly,2022,4(36):815-816.
-
4Reported Cases and Deaths of National Notifiable Infectious Diseases-China,July 2022[J].China CDC weekly,2022,4(43):974-975.
-
5Na Chen,Min-Jia Qian,Ru-Hui Zhang,Qi-Qi Gao,Chao-Chao He,Ya-Ke Yao,Jian-Ying Zhou,Hua Zhou.Tislelizumab-related enteritis successfully treated with adalimumab:A case report[J].World Journal of Clinical Cases,2022,10(28):10186-10192. 被引量：1
-
6Li Qi,Wenge Tang,Ju Wang,Yu Xiong,Yi Yuan,Baisong Li,Lin Yang,Tingting Li,Lianjian Yang,Xiaoyuan Su,Qin Li,Lijie Zhang.An Outbreak of SARS-CoV-2 Omicron Subvariant BA.2.76 in an Outdoor Park—Chongqing Municipality,China,August 2022[J].China CDC weekly,2022,4(46):1039-1042. 被引量：2
-
7Alvin Oliver Payus,Malehah Mohd Noh,Nornazirah Azizan,Raman Muthukaruppan Chettiar.SARS-CoV-2-induced liver injury:A review article on the high-risk populations,manifestations,mechanisms,pathological changes,management,and outcomes[J].World Journal of Gastroenterology,2022,28(39):5723-5730.
-
8Bin Yu,Junbiao Chang.The first Chinese oral anti-COVID-19 drug Azvudine launched[J].The Innovation,2022,3(6):33-34. 被引量：8
-
9Junyan Jin,Xiuwen Wang,Raphael Carapito,Christiane Moog,Bin Su.Advances in Research on COVID-19 Vaccination for People Living with HIV[J].Infectious Diseases & Immunity,2022,2(4):213-218. 被引量：1
-
10Zhenlin Yang,Cheng Li,Yuanlin Song,Tianlei Ying,Yanling Wu.Inhalable antibodies for the treatment of COVID-19[J].The Innovation,2022,3(6):23-24. 被引量：1
